Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Enanta Pharmaceuticals (ENTA) has a market cap of $0.10 billion USD. According to our data, Enanta Pharmaceuticals is ranked No.7547 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.10 B |
-15.83%
|
| Dec 31, 2024 | $0.12 B |
-38.89%
|
| Dec 29, 2023 | $0.20 B |
-79.77%
|
| Dec 30, 2022 | $0.99 B |
-37.79%
|
| Dec 31, 2021 | $1.60 B |
77.62%
|
| Dec 31, 2020 | $0.90 B |
-31.85%
|
| Dec 31, 2019 | $1.32 B |
-12.78%
|
| Dec 31, 2018 | $1.51 B |
20.71%
|
| Dec 29, 2017 | $1.25 B |
75.16%
|
| Dec 30, 2016 | $0.71 B |
1.45%
|
| Dec 31, 2015 | $0.70 B |
-35.06%
|
| Dec 31, 2014 | $1.08 B |
86.40%
|
| Dec 31, 2013 | $0.58 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$218.28 B |
1.163 B
|
Switzerland
|
 GlaxoSmithKline
GSK
|
$72.32 B |
0.003 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Sanofi
SNY
|
$127.25 B |
3.672 B
|
France
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
| Market Cap | = | ENTA Stock Price | * | ENTA Shares Outstanding |
| = | $4.84 | * | 21.33 M | |
| = | $0.10 B |